OPL
Click for more information
0.00% 2.7¢ opyl limited

Patient recruitment is a significant problem in biopharma. It’s...

  1. SCudane
    130 Posts.
    lightbulb Created with Sketch. 12
    clock Created with Sketch.
    04/08/22
    01:01
    Post #: 62910626
    Patient recruitment is a significant problem in biopharma. It’s one of the major reasons why trials are delayed. This co can really contribute in solving this problem.

    they have 1.13mill in funding (loan facility + cash). Net spend this quarter was high, should be a profitable quarter going forward potentially with the previous + upcoming contracts they are going to sign
    OPL Price at posting: 5.9¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS AI stocks: What to expect in 2024-25
right-arrow Created with Sketch.
RIO Rio registers 2% drop in iron ore production in 2nd quarter of 2024
right-arrow Created with Sketch.
NEWS Bitcoin investors need to know the risks
right-arrow Created with Sketch.
NEWS Almonty locks in govt agreement for tungsten oxide plant in South Korea
right-arrow Created with Sketch.
IVR Investigator Resources hits 8m @ 1.06% copper on-site Stuart Shelf JV project acreage
right-arrow Created with Sketch.
BHP BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning
right-arrow Created with Sketch.
watchlist Created with Sketch. Add OPL (ASX) to my watchlist
(20min delay)
Last
2.7¢ 		Change
0.000(0.00%) 		Mkt cap ! $4.609M
Open High Low Value Volume
2.7¢ 2.7¢ 2.7¢ $6 209

Buyers (Bids)

No. Vol. Price($)
2 100017 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 542644 3
View Market Depth
Last trade - 12.31pm 17/07/2024 (20 minute delay) ?
OPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.